Proactive Investors - Run By Investors For Investors

Tissue Regenix signs first European distribution deals for knee repair treatment

Data from OrthoPure XT has shown “a statistically significant improvement” in patients compared with the current gold standard
knee x-ray
Obesity and more injuries from sport are leading to more people needing knee surgery

Tissue Regenix Group PLC (LON:TRX) has signed the first European distribution agreements for OrthoPure XT as the knee repair treatment continues to return positive data from patients.

Early clinical data put forward to support the CE mark application for OrthoPure XT has shown the “clinical relevance” of the product, with patients displaying “a statistically significant improvement” in recovery compared to the current gold standard.

“We are extremely encouraged by the initial results returned from the study,” said TRX Orthopaedics’ commercial director Peter Hamer.

“Having entered our first distributor agreements, which highlight the demand and market opportunity for OrthoPure XT, we remain on track for launch of OrthoPure XT by the end of the first half of 2017.”

The CE mark approval also remains on schedule for the first half of 2017, the regenerative medical devices company added.

Shares were up 2% to 16.5p in early deals on Monday.

View full TRX profile

Tissue Regenix Group PLC Timeline

Related Articles

February 06 2017
The hybrid pharma services and drug development group has hit some key milestones over this year as trial results are eyed.
February 14 2017
It has unveiled plans to raise as much as £12mln, which should transform the business.
picture of someone with head pain
December 07 2016
Its strategy is to develop cell lines for "off the-shelf" therapies to treat serious conditions

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use